Trials / Conditions / Refractory Aggressive Non-Hodgkin Lymphoma
Refractory Aggressive Non-Hodgkin Lymphoma
3 registered clinical trials studyying Refractory Aggressive Non-Hodgkin Lymphoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Hypoxia-Specific Imaging to Predict Outcomes of Chimeric Antigen Receptor T-cell Therapy NCT04409314 | University of California, San Francisco | — |
| Completed | Nab-paclitaxel/Rituximab-coated Nanoparticle AR160 in Treating Patients With Relapsed or Refractory B-Cell Non NCT03003546 | Mayo Clinic | Phase 1 |
| Completed | Pembrolizumab and External Beam Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin NCT03210662 | M.D. Anderson Cancer Center | Phase 2 |